Abstract
Ten patients in whom the clinical findings were consistent with the syndrome variously described as ‘benign myalgic encephalomyelitis’, ‘epidemic neuromyasthenia’, ‘Royal Free disease’ and ‘Icelandic disease’ were investigated for blood levels of myoglobin and various enzymes. Although there is no clinical resemblance between the two diseases, the biochemical pattern bears a close similarity to that found in Duchenne muscular dystrophy (DMD) though differing sharply in that no rise in creatinine kinase levels was found. These findings are discussed with particular reference to recent suggestions that the permeability of cell membranes may be impaired by changes in intracellular energy mechanisms.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adornato B. T., Kagen L. J., Engel W. K. Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection. Lancet. 1978 Sep 2;2(8088):499–501. doi: 10.1016/s0140-6736(78)92221-3. [DOI] [PubMed] [Google Scholar]
- Hansen K. N., Lademann A., Nørgaard-Pedersen B. Potential of radioimmunoassay of myoglobin in amniotic fluid and serum in prenatal diagnosis of Duchenne muscular dystrophy. Lancet. 1978 Dec 9;2(8102):1250–1251. doi: 10.1016/s0140-6736(78)92117-7. [DOI] [PubMed] [Google Scholar]
- Wilkinson J. H. Clinical enzymology. J R Soc Med. 1978 Apr;71(4):241–243. doi: 10.1177/014107687807100401. [DOI] [PMC free article] [PubMed] [Google Scholar]